R01 CA124573/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	2
2011	1
2012	2
2014	1
2016	1
2018	1
2024	2

1

Prospective Study of Serial ¹⁸F-FDG PET and ¹⁸F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.

Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM. Peterson LM, et al. J Nucl Med. 2018 Dec;59(12):1823-1830. doi: 10.2967/jnumed.118.211102. Epub 2018 May 10. J Nucl Med. 2018. PMID: 29748233 Free PMC article.

2

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA. Doot RK, et al. J Nucl Med. 2010 Apr;51(4):521-7. doi: 10.2967/jnumed.109.070052. Epub 2010 Mar 17. J Nucl Med. 2010. PMID: 20237040 Free PMC article. Clinical Trial.

3

Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

Doot RK, Scheuermann JS, Christian PE, Karp JS, Kinahan PE. Doot RK, et al. Med Phys. 2010 Nov;37(11):6035-46. doi: 10.1118/1.3499298. Med Phys. 2010. PMID: 21158315 Free PMC article.

4

Repeatability of ¹⁸F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.

Muzi M, Peterson LM, Specht JM, Hippe DS, Novakova-Jiresova A, Lee JH, Kurland BF, Mankoff DA, Obuchowski N, Linden HM, Kinahan PE. Muzi M, et al. EJNMMI Res. 2024 Mar 27;14(1):32. doi: 10.1186/s13550-024-01093-7. EJNMMI Res. 2024. PMID: 38536511 Free PMC article.

5

Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.

Muzi M, Peterson LM, Specht JM, Hippe DS, Novakova-Jiresova A, Lee JH, Kurland BF, Mankoff DA, Obuchowski N, Linden HM, Kinahan PE. Muzi M, et al. Res Sq [Preprint]. 2024 Jan 16:rs.3.rs-3818932. doi: 10.21203/rs.3.rs-3818932/v1. Res Sq. 2024. PMID: 38313279 Free PMC article. Updated. Preprint.

6

Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.

Doot RK, McDonald ES, Mankoff DA. Doot RK, et al. Clin Transl Imaging. 2014 Aug 1;2(4):295-303. doi: 10.1007/s40336-014-0071-1. Clin Transl Imaging. 2014. PMID: 25229053 Free PMC article.

7

Accuracy of CT-based attenuation correction in PET/CT bone imaging.

Abella M, Alessio AM, Mankoff DA, MacDonald LR, Vaquero JJ, Desco M, Kinahan PE. Abella M, et al. Phys Med Biol. 2012 May 7;57(9):2477-90. doi: 10.1088/0031-9155/57/9/2477. Epub 2012 Apr 5. Phys Med Biol. 2012. PMID: 22481547 Free PMC article.

8

Design considerations for using PET as a response measure in single site and multicenter clinical trials.

Doot RK, Kurland BF, Kinahan PE, Mankoff DA. Doot RK, et al. Acad Radiol. 2012 Feb;19(2):184-90. doi: 10.1016/j.acra.2011.10.008. Epub 2011 Nov 21. Acad Radiol. 2012. PMID: 22104290 Free PMC article.

9

Getting the Most out of 18F-FDG PET Scans: The Predictive Value of 18F-FDG PET-Derived Blood Flow Estimates for Breast Cancer.

Doot RK. Doot RK. J Nucl Med. 2016 Nov;57(11):1667-1668. doi: 10.2967/jnumed.116.175687. Epub 2016 Jun 3. J Nucl Med. 2016. PMID: 27261517 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year